Takeda Pharmaceutical Co ADR (NYSE:TAK) currently has a daily average trading volume of 1.96M but it saw 1551660 shares traded in last market. With a market cap of 46.45B USD, the company’s current market price of $14.65 came rising about 0.76 while comparing to the previous closing price of $14.54. In past 52 weeks, the stock remained buoying in the range of price level as high as $15.37 and as low as $12.57. In the recent trading on the day, stock has struck highest price mark of $14.612 while lowest mark touched by it was $14.7299.
Taking a look at 20-day trading activity of Takeda Pharmaceutical Co ADR (TAK) gives us an average price of $14.71, while its current price level is -4.68% below from 52-week high level whereas it is 16.50% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $14.49 while that of 200 days or SMA-200 reads an average of $14.01. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.84% during that period while stretching the period over a month that increases to 1.91%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 51.54 which implies that the stock is in neutral territory.
BofA Securities upgraded its recommendation for the stock as a “Buy” from “Neutral” on March 16, 2023 while assigning a price target of $20. Cowen also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $21 and $24.
Over the week, TAK’s stock price is moving 2.16% up while it is -3.49% when we observe its performance for the past one month. Year-to-date it is 10.65% up and over the past year, the stock is showing an upside performance of 11.15%.
Currently, Takeda Pharmaceutical Co ADR’s total number of outstanding shares is 3.17B with 0.01% of that held by the insiders while 2.32% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 1.77% and return on equity (ROE) at 2.87%. It has a price to earnings ratio (P/E ratio) of 34.45 while having a 29.56 of forward P/E ratio. Stock’s beta reads 0.30. Stock has a price to book (P/B) ratio of 0.98 while price to sale or P/S ratio amounts to 1.54. Its return on asset (ROA) is 1.38% on average.
